LifeSci Consulting

What LifeSci Consulting does

LifeSci Consulting is a boutique strategy consulting and transaction advisory firm serving the global life sciences industry. Established in 2019 as a spin-out from LifeSci Partners' Partnering & Analytics division, the firm delivers three integrated service lines: Corporate Strategy & Business Development (commercial opportunity assessment, valuation, indication and pipeline prioritization, buy-side and sell-side transaction advisory); Commercial Strategy (new product planning, go-to-market and launch strategy, competitive intelligence, brand planning, pricing and market access); and Organizational Strategy & Operations (operating model design, operational excellence, enterprise cost transformation, outsourcing excellence, and program delivery). The firm differentiates through a network of 5,000+ global industry contacts, a 15-year-plus track record of $8B+ in cumulative transaction value, and 250+ strategy consulting engagements, with senior leaders holding PhDs, MDs, and prior experience at Trinity Life Sciences, ClearView Healthcare Partners, L.E.K. Consulting, Accenture, and Deloitte.

The firm operates a direct enterprise engagement model, acquiring clients through senior-level outreach to pharmaceutical, biotech, and life sciences companies and supporting senior executives through strategy planning, transaction execution, and operational transformation. Revenue is generated through bespoke, project-based professional services fees and transaction-based advisory fees, with no publicly disclosed pricing. The client base spans global pharma majors (Johnson & Johnson, Janssen, AstraZeneca, Novo Nordisk, Leo Pharma, Menarini, Grunenthal, Hanmi) and biotech and cell therapy innovators (iCT, Lyell, Sernova, Evotec, Biosplice, Aptose, Timber Pharmaceuticals), with marquee engagements ranging from $27M equity investments to $1.04B+ licensing and acquisition transactions.

LifeSci Consulting is headquartered in New York (1700 Broadway) with general offices in Boston, Los Angeles, Chicago, San Diego, and Charlotte; a European regional headquarters in London led by Cristiano Musso, MD; and a Tel Aviv office covering Israel and the Middle East. The firm is privately held with no external institutional investment disclosed, and ownership appears concentrated among the founding and senior management team. Marketing relies on targeted thought leadership (e.g., white papers on cell therapy commercialization), LinkedIn presence, and direct senior engagement, with no channel partners or marketplace distribution.

Name

LifeSci Consulting

Legal name

LifeSci Consulting, LLC

Website

https://lifesciconsulting.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

LifeSci Consulting is a boutique life sciences strategy consulting and transaction advisory firm serving pharmaceutical, biotech, and cell therapy companies globally. It offers corporate strategy and BD, commercial strategy, and organizational strategy services, supported by a 5,000+ contact global network and $8B+ in cumulative deal value.

Ownership category

akta.pro rank

Product category

Life Sciences Management Consulting

NAICS

Management Consulting Services (54161), Administrative Management and General Management Consulting Services (541611), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA), Corporate Strategy Advisory (BPAHADAA), Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG)

Keywords

• Life sciences consulting
• Pharmaceutical strategy advisory
• Biotech transaction advisory
• Commercial strategy consulting
• Healthcare M&A advisory

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Strategy Consulting Engagements: Professional services fees generated from corporate strategy, commercial strategy, and organizational strategy consulting engagements. Engagements are typically project-based with scope defined per client need.
2. Transaction Advisory Services: Fees from buy-side and sell-side transaction advisory, including M&A support, licensing deals, and capital-raising advisory. Revenue generated on a transaction basis with total deal value exceeding $8B.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

LifeSci Consulting is a boutique strategy, operations, and transaction advisory firm serving the global life sciences industry. The firm delivers three service lines: Corporate Strategy & Business Development (including opportunity assessment, valuation, buy-side/sell-side diligence, and transaction advisory), Commercial Strategy (new product planning, go-to-market/launch strategy, competitive strategy, brand planning, and pricing/market access), and Organizational Strategy & Operations (operating model design, cost transformation, outsourcing excellence, and program delivery). It has supported transactions totaling over $8B in deal value and executed more than 250 strategy consulting engagements.

Product overview

LifeSci Consulting is a global strategy and operations and transaction advisory firm serving clients across the life sciences industry. The firm offers three primary service lines: Corporate Strategy & Business Development (supporting strategic planning, valuation, and M&A advisory), Commercial Strategy (covering new product planning, go-to-market, competitive strategy, and market access), and Organizational Strategy & Operations (focused on operating model transformation, cost optimization, and program delivery).

Differentiator

Problem solved

Functional benefit

Products and services

• Corporate Strategy & Business Development Supports internal strategic planning and corporate development initiatives for life sciences companies. Includes commercial opportunity assessment, asset valuation (rNPV and comparable analysis), indication/pipeline prioritization, search & evaluation, buy-side diligence, and sell-side transaction advisory. Serves pharmaceutical, biotech, and life sciences companies pursuing strategic transactions, licensing deals, and corporate development programs.
• Commercial Strategy Develops strategies and solutions for products across the lifecycle to optimize product profiles, drive early commercial success, and maximize product value. Includes new product planning, go-to-market and launch strategy, competitive strategy, brand planning and lifecycle management, and pricing and market access. Serves life sciences companies preparing for or executing product launches and optimizing commercial performance.
• Organizational Strategy & Operations Delivers tailored solutions and programs that transform core business operations to maximize operational and cost efficiencies. Includes corporate and functional strategy, operational excellence, enterprise cost transformation, outsourcing excellence, and programs and performance. Serves life sciences companies seeking operating model redesign, cost optimization, and organizational change management.

Named customers17 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• McKinsey & Company (Life Sciences practice): Largest generalist strategy consulting firm with a deep pharma and biotech practice; competes on large enterprise strategy and corporate development engagements that LifeSci also targets.
• Bain & Company (Healthcare practice): Global strategy consulting firm with dedicated Healthcare and Life Sciences practices; competes for M&A advisory and corporate strategy mandates at large pharma and biotech clients.
• Accenture (Life Sciences): Global consulting and technology firm with a sizable Life Sciences practice spanning strategy, transformation, and operations — overlaps with LifeSci's Organizational Strategy & Operations service line at enterprise scale.
• Charles River Associates (Life Sciences): Consulting firm with a Life Sciences practice offering commercial strategy, pricing, and transaction support — comparable in scope with LifeSci's pricing/market access and transaction advisory offerings.
• L.E.K. Consulting: Global management consulting firm with a large dedicated Life Sciences practice covering strategy, M&A, and commercial advisory; competes for the same enterprise pharma and biotech mandates but operates at materially greater scale.

Direct peers

• KMR Consulting: Boutique life sciences consulting firm focused on commercial strategy and transaction advisory for pharma and biotech clients, similar in scale and service mix to LifeSci Consulting.
• Trinity Life Sciences: Specialist life sciences strategy and commercial consulting firm, a direct competitor for commercial strategy, market access, and transaction advisory engagements serving pharma and biotech clients.
• ZS Associates: Large specialized consulting firm serving pharma, biotech, and medtech with commercial strategy, sales/marketing operations, and analytics — overlapping directly with LifeSci's commercial strategy and pricing/market access offerings.
• ClearView Healthcare Partners: Life sciences consulting firm focused on strategy, commercial diligence, and new product planning for pharma and biotech, similar service portfolio and client base as LifeSci Consulting.
• Putnam Associates: Pharma and biotech focused strategy consulting firm with strong commercial strategy and market access practices; competes head-to-head with LifeSci on commercial opportunity assessments and global pricing/access work.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/lifesci-consulting-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeSci Consulting